Brian Phillips

Brian Phillips is a highly experienced scientist currently serving as a Principal Scientist at Evonik, where responsibilities include formulation and process development involving Eudragit polymers for oral solid dosage forms. Prior to this role, Brian held the position of Scientist III at Ashland, leading projects for a new grade of hydroxypropylcellulose and co-inventing a new grade of crospovidone. Earlier experiences include working as a Scientist II at Ashland, focusing on functional excipients and customer education, and as a Process Analyst at AstraZeneca, where collaboration with the Formulation team enhanced manufacturing processes for key products. Brian is pursuing a Master of Science in Chemical and Biochemical Engineering at Rutgers University and holds an Honors Bachelor's degree in Chemical Engineering from the University of Delaware.